- Endo buys American Medical Systems for $2.9bn
- Valeant goes hostile and offers $73/share for Cephalon; withdrawn
- Cephalon moves into generics via CHF622.5mm Mepha buy
- Biovail buys Valeant in $3.3bn reverse merger
- Gemin X takes $225mm up front in takeover by Cephalon
- Cephalon to acquire ChemGenex for $A225mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.